Related Experiment Video
Updated: Nov 13, 2025
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
COVID-19-related Ocular Hypertension Secondary to Anterior Uveitis as Part of a Multisystemic Inflammatory Syndrome
Ruiz S Alonso1, Fabio O M Alonso2, Bruno F Fernandes3
1Department of Ophthalmology, Antonio Pedro University Hospital, Fluminense Federal University.
Insights
This case study highlights a rare instance of severe ocular complications from Coronavirus Disease 2019 (COVID-19). A patient developed sight-threatening ocular hypertension due to uveitis, requiring surgical intervention.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Systemic Inflammatory Syndromes
Background:
- Ocular complications of Coronavirus Disease 2019 (COVID-19) are generally considered mild and self-limiting.
- No prior reports of sight-threatening ocular events associated with COVID-19 exist in medical literature.
Abstract:
It is the consensus of the medical community that ocular complications associated with Coronavirus Disease 2019 (COVID-19) are mild, self-limiting, and there are no reports to date of a sight-threatening event. We report a patient with a systemic inflammatory syndrome in the context of COVID-19, with ophthalmological (uveitis), dermatological (erythema and skin nodules), and cardiovascular (edema) manifestations. The anterior uveitis led to an increase in the intraocular pressure that failed to respond to clinical treatment and prompted a surgical intervention to save the vision. To the best of our knowledge, this is the first report of a COVID-19-related ocular hypertension. Timely surgical intervention was key to save the vision in the patient's only eye.
Related Concept Videos
01:25Glaucoma: Overview
01:28Angle Closure Glaucoma: Treatment
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...